高度糖化最終製品市場：製品タイプ別、用途別、エンドユーザー別、地域別

世界の高度糖化最終（AGE）製品市場は、2025年には18億7,000万米ドルと推定され、2032年には30億1,000万米ドルに達すると予測され、2025～2032年までの年間平均成長率（CAGR）は7.0%で成長する見込みです。

図.高度糖化最終製品市場シェア（%）、2025年地域別

高度糖化最終製品市場の世界の成長は、糖尿病と高血圧の有病率の増加と、世界の高齢者の増加によってもたらされます。AGEsは、還元糖または炭水化物とタンパク質または脂質との間の非酵素的反応の結果として体内で形成される分子です。AGEが体内に蓄積すると、酸化ストレスや炎症が増加し、様々な慢性疾患のリスクを高めています。健康意識の高まりにより、革新的なAGE阻害療法の開発に焦点を当てた研究開発が増え、加齢に関連した症状を効果的に管理するためのAGE測定ツールや薬剤の需要が高まる可能性があります。

市場力学

先進糖化最終生成物の世界市場成長の原動力は、糖尿病やその他の生活習慣病患者の増加、慢性疾患にかかりやすい高齢化人口の増加、市場開拓における医療費の増加、より効果的なAGE阻害剤の開発に向けた研究開発の進行といった要因です。しかし、AGE検出技術に関連するコストの高さや認知度の低さが市場成長の妨げになる可能性があります。低コストのポイントオブケアAGE測定装置の開発、研究機関との協力体制の確立、新興国市場への展開などが、市場開拓の機会となる可能性があります。

本調査の主要特徴

本レポートでは、世界の高度糖化最終製品市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模（10億米ドル）と年間平均成長率（CAGR%）を掲載しています。

さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて解説しています。

また市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の高度糖化最終製品市場の主要企業をプロファイルしています。

本調査の対象となる主要企業には、Keryx Biopharmaceuticals Inc.、Alnylam Pharmaceuticals Inc.、Amrax Bioなどが含まれます。

本レポートから洞察により、マーケティング担当者や企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。

世界の高度糖化最終製品市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。

利害関係者は、世界の高度糖化最終製品市場分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• 一貫型機会マップ（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の高度糖化最終製品市場-コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 世界の高度糖化最終製品市場、タイプ別、2020～2032年（10億米ドル）

• イントロダクション
• 非蛍光
• 蛍光

第6章 世界の高度糖化最終製品市場、用途別、2020～2032年（10億米ドル）

• イントロダクション
• 糖尿病の合併症
• がん
• 骨疾患
• 神経変性疾患
• その他

第7章 世界の高度糖化最終製品市場、エンドユーザー別、2020～2032年（10億米ドル）

• イントロダクション
• 病院
• 専門クリニック
• 在宅医療
• その他

第8章 世界の高度糖化最終製品市場、地域別、2020～2032年（10億米ドル）

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• 企業プロファイル
  • Alteon Inc.
  • Plexxikon Inc.
  • Phenomenome Discoveries Inc.
  • Kowa Company Ltd.
  • Novartis International AG
  • OPKO Health, Inc.
  • DiabetOmics, Inc.
  • Amadori Scientific
  • LabCorp
  • Quest Diagnostics Incorporated
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Sanofi SA

第10章 アナリストの推奨事項

• 隆盛と衰退
• 一貫型機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Advanced Glycation End Products Market is estimated to be valued at USD 1.87 Bn in 2025 and is expected to reach USD 3.01 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032.

Figure. Advanced Glycation End Products Market Share (%), By Region 2025

Global advanced glycation end products market growth is driven by increasing prevalence of diabetes and hypertension coupled with rising geriatric population worldwide. AGEs are molecules formed internally in the body as a result of non-enzymatic reactions between reducing sugars or carbohydrates and proteins or lipids. Accumulation of AGEs in the body causes damage by increasing oxidative stress and inflammation which can increase the risk of various chronic diseases. Due to growing health awareness, more research studies focusing on developing innovative AGE inhibition therapies can boost demand for AGE measurement tools and drugs to manage age-related conditions effectively.

Market Dynamics:

Global advanced glycation end products market growth is driven by factors like rising cases of diabetes and other lifestyle-related disorders, increasing aging population susceptible to chronic diseases, growing healthcare expenditure in developing nations, and ongoing research efforts to develop more effective AGE inhibitors. However, high costs associated with AGE detection technologies and lack of awareness can hamper the market growth. Developing low-cost point-of-care AGE measurement devices, establishing collaboration with research institutes, and expanding to emerging regions can offer opportunities for market players.

Key Features of the Study:

This report provides in-depth analysis of the global advanced glycation end products market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global advanced glycation end products market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Keryx Biopharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Amrax Bio, and others

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global advanced glycation end products market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global advanced glycation end products market

Detailed Segmentation-

• By Type
  • Non-fluorescent AGEs
  • Fluorescent AGEs
• By Application
  • Diabetic Complications
  • Cancer
  • Bone Diseases
  • Neurodegenerative Diseases
  • Others
• By End User
  • Hospitals
  • Specialty Clinics
  • Homecare Settings
  • Other
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Alteon Inc.
  • Plexxikon Inc.
  • Phenomenome Discoveries Inc.
  • Kowa Company Ltd.
  • Novartis International AG
  • OPKO Health, Inc.
  • DiabetOmics, Inc.
  • Amadori Scientific
  • LabCorp
  • Quest Diagnostics Incorporated
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Sanofi S.A.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Advanced Glycation End Products Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Advanced Glycation End Products Market, By Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Non-fluorescent AGEs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Fluorescent AGEs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Advanced Glycation End Products Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Diabetic Complications
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cancer
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Bone Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurodegenerative Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Advanced Glycation End Products Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare Settings
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Advanced Glycation End Products Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Alteon Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Plexxikon Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Phenomenome Discoveries Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Kowa Company Ltd.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Novartis International AG
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • OPKO Health, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • DiabetOmics, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Amadori Scientific
  • LabCorp
  • Quest Diagnostics Incorporated
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Sanofi S.A.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. Reference and Research Methodology

• References
• Research Methodology
• About us and Sales Contact